Links

Homepage

Stock List

Search by Ticker

News

Login

Theratechnologies (TSX:TH)
Stock Analysis

TH.TO3.57
▼ -1.11%-0.04

Stock Analysis

The following stock analysis is based on 8 years of data (i.e. since Aug 07, 2012). All the stock history has been downloaded.

Stock Exchange

Theratechnologies trades on the Toronto exchange in CAD dollars.

Sector

It is in the sector.

Current Status of Theratechnologies

It is currently trading at $3.57 ($3.61 the previous day).

Financials

The current Canada / US exchange rate is 1.3266.



Will This Trend Continue?

The year over year average increase is 8.0% per year assuming steady exponential growth. The actual 5 year average is 56.98. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year4.1021782178218-46.5- Below Average
2 year7.6710080645161-15.5- Below Average
3 year9.07924369747980+ Above Average
4 year5.0446963562753146.8+ Above Average
5 year2.0443346007605120.1+ Above Average

Risk

The worst drop it has had in recent years is -84.4%. It has a shape to the stock curve, which means

Stock shape test

DAYS AG0PRICE
103.33RISING
303.11RISING
602.47RISING
1502.95DROPPING
3655.41DROPPING
80013.5DROPPING
12006.54RISING
16001.78RISING
20000.56RISING


With an average increase of 8.0% year over year, if Theratechnologies is bought at the worst time, Stockmarketizer analysts estimate it will take 126.6 months before the stock will recover to the original purchase price.

Tradingview BuySell Widget

Yahoo News Feed

Theratechnologies to Present at the Canaccord Genuity 40th Annual Growth Conference on August 12, 2020

Thu, 30 Jul 2020 11:30:00 MONTREAL, July 30, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that Philippe Dubuc, the Senior Vice President and Chief Financial Officer of Theratechnologies, will present at the Canaccord Genuity Growth Conference on ...... Read Full Article

Theratechnologies Reports That Tesamorelin Improves Liver Health

Thu, 23 Jul 2020 20:01:00 Sub-analysis of MGH study helps better demonstrate how tesamorelin reduces liver fat Positive impact of tesamorelin on oxidative phosphorylation, inflammation, tissue repair and cell divisionMONTREAL, July 23, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, ...... Read Full Article

Edited Transcript of TH.TO earnings conference call or presentation 15-Jul-20 12:30pm GMT

Tue, 21 Jul 2020 02:09:43 Q2 2020 Theratechnologies Inc Earnings Call... Read Full Article

Analysts Have Been Trimming Their Theratechnologies Inc. (TSE:TH) Price Target After Its Latest Report

Sat, 18 Jul 2020 14:31:57 Last week, you might have seen that Theratechnologies Inc. (TSE:TH) released its quarterly result to the market. The...... Read Full Article

Announcements in Conjunction With Theratechnologies Annual Meeting

Thu, 16 Jul 2020 16:23:40 MONTREAL, July 16, 2020 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today held its annual meeting of.... Read Full Article

Theratechnologies Inc. (THTX) Q2 2020 Earnings Call Transcript

Thu, 16 Jul 2020 02:30:56 Mr. Boucher, please go ahead. Paul Levesque, President the Chief Executive Officer of Theratechnologies; as well as Mr. Philippe Dubuc, Senior Vice President and Chief Financial Officer, will be the speakers on today's call.... Read Full Article

Theratechnologies Announces Financial Resultsandand#160;for the Second Quarter of Fiscal 2020

Wed, 15 Jul 2020 11:30:10 -Total product revenues of $17.2M, a 10% increase compared to Q2 2019 and 9% increase compared to Q1 2020- -Trogarzo® net revenues up 13.2% and combined EGRIFTA®, EGRIFTA.... Read Full Article

Theratechnologies Confirms Bioequivalence of New Tesamorelin Formulation

Tue, 07 Jul 2020 11:30:10 Theratechnologies Inc. (Theratechnologies) (TH.TO) (THTX), a commercial-stage biopharmaceutical company, is pleased to announce that it has successfully completed a bioequivalence study evaluating a new formulation of tesamorelin compared to the original formulation approved by the FDA (F1). This new ...... Read Full Article

Theratechnologies Announces Ibalizumab Inhibits HIV-2 In Vitro

Mon, 06 Jul 2020 11:30:10 Theratechnologies Inc. (Theratechnologies) (TH.TO) (THTX), a commercial-stage biopharmaceutical company, is pleased to announce that data presented at the 23rd International AIDS Conference virtual meeting, demonstrates that ibalizumab is active in vitro against group A and group B HIV-2. The ...... Read Full Article

New Data Show Theratechnologies’ SORT1+ Technology is Effective in Many Treatment-Resistant Cancers

Mon, 22 Jun 2020 11:30:10 Theratechnologies Inc. (Theratechnologies) (TH.TO) (THTX), a commercial-stage biopharmaceutical company, is pleased to announce that new data featuring its investigational sortilin 1 (SORT1)-targeting peptide-drug conjugate technology will be presented in three posters at the American Association for Cancer Research’s ...... Read Full Article

Edited Transcript of TH.TO earnings conference call or presentation 14-Apr-20 12:30pm GMT

Tue, 09 Jun 2020 10:49:53 Q1 2020 Theratechnologies Inc Earnings Call... Read Full Article

Theratechnologies Unveils New Positive Data for Its Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Cancers

Fri, 15 May 2020 11:30:10 Theratechnologies Inc. (Theratechnologies) (TH.TO) (THTX), a commercial-stage biopharmaceutical company, today announced new positive results for its investigational Sortilin (SORT1) targeting peptide-drug conjugates (PDCs) which will be presented in three posters during AACR’s virtual annual meeting II on June 22, 2020. ...... Read Full Article

Theratechnologies to Present at the RBC Capital Markets Global Healthcare Conference on May 19, 2020

Tue, 12 May 2020 11:30:10 MONTREAL, May 12, 2020 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that management.... Read Full Article

Theratechnologies Announces New Positive Results for two Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Ovarian Cancer

Mon, 27 Apr 2020 11:30:10 Theratechnologies Inc. (Theratechnologies) (TH.TO) (THTX), a commercial-stage biopharmaceutical company, today announced that new positive results about its two investigational peptide-drug conjugates (PDC) TH1902 and TH1904 will be presented tomorrow during an oral presentation at a virtual session of the ...... Read Full Article

Theratechnologies to Make Oral Presentation on Oncology Platform During AACR Virtual Annual Meeting

Thu, 16 Apr 2020 19:23:21 Theratechnologies Inc. (Theratechnologies) (TH.TO) (THTX), a commercial-stage biopharmaceutical company, today announced that it will make an oral presentation on new results from its sortilin targeting oncology platform during a virtual session of the annual meeting of the American Association ...... Read Full Article

Theratechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Thu, 16 Apr 2020 11:30:10 Theratechnologies Inc., or Theratechnologies (TH.TO) (THTX), a commercial-stage biopharmaceutical company, announced today that Paul Lévesque, the current President and Chief Executive Officer of Theratechnologies, was granted 487,421 stock options, or Options, to purchase an aggregate of 487,421 common shares of ...... Read Full Article

Theratechnologies Announces Financial Results for the First Quarter of 2020

Tue, 14 Apr 2020 11:30:10 Theratechnologies Inc. (Theratechnologies) (TH.TO) (THTX), a commercial-stage biopharmaceutical company, today announced its financial results for the first quarter ended February 29, 2020. Financial results presented in this press release are taken from the Company’s Management's Discussion and Analysis, or MDandA, ...... Read Full Article

THERATECHNOLOGIES PROVIDES BUSINESS UPDATE RELATED TO CURRENT COVID-19 SITUATION

Tue, 31 Mar 2020 11:30:10 Theratechnologies Inc. (Theratechnologies) (TH.TO) (THTX), a commercial-stage biopharmaceutical company, today issued an update on the Company’s activities in relation to the current worldwide COVID-19 pandemic. “Theratechnologies’ focus amidst the COVID-19 pandemic has been to ensure that current and ...... Read Full Article

Visceral Fat is a Predictor of Liver Fibrosis and Fibrosis Progression in People Living With HIV

Wed, 11 Mar 2020 16:00:10 Theratechnologies Inc. (Theratechnologies) (TH.TO) (THTX), a commercial-stage biopharmaceutical company, is pleased to announce that Dr. Lindsay Fourman, from Harvard Medical School, presented data demonstrating that visceral fat is a clinical predictor of liver fibrosis and liver fibrosis progression in ...... Read Full Article

Change to Theratechnologies Management

Mon, 02 Mar 2020 13:00:00 The board of directors of Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) is pleased to announce the appointment of Paul Lévesque as the companyand's President and CEO, effective April 6, 2020, replacing Luc Tanguay, who is retiring after a 23-year career. Mr. ...... Read Full Article
<